C

Cergentis B.V.

38 employees

Cergentis provides services and kits based on its proprietary 'Targeted Locus Amplification' (TLA) technology.

Basic info

Industry

biotechnology research

Sectors

transgenic animal models
Biotechnology
quality control
integration site sequencing
next generation sequencing
Targeted Gene Sequencing
gene therapy
genetic quality control
genetic engineering
solutions provider
clonality assurance
genetic stability analysis
transgene sequencing
Complete Gene Sequencing
cell therapy
Genetics
Medical
atmp
Translocation detection
CHO cells
cell line characterization
gene fusion detection

Date founded

2012

Funding rounds raised

Total raised

$2.3M

from 1 investors over 1 rounds

C

Cergentis B.V. raised $2.3M on May 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ